Pediatric Healthcare Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Type (Chronic Illness and Acute Illness), Treatment and Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >4.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Pediatric healthcare market studied was anticipated to grow with a CAGR of nearly 4.6% during the forecast period. The major factors attributing to the growth of the pediatric healthcare market are a rise in the number of deaths due to various diseases, viral infections, and malnutrition every year. For instance, according to estimates published by The United Nations Children's Fund (UNICEF) in November 2018, every year about 3 million deaths occur due to pediatric pneumonia worldwide which demands the earlier diagnosis and efficient treatment fueling the global market. Furthermore, the rise in government support, combined with increased research activities in technological advancements, fuel the pediatric healthcare market.

Scope of the Report

Pediatric healthcare is a branch of medicine that deals with the medical care, their development and related diseases of infants, children, and adolescents. The pediatric healthcare market grows significantly as children often suffer from gastrointestinal, allergic, respiratory and other chronic diseases owing to their lower immunity.

Type
Chronic Illness
Acute Illness
Treatment
Vaccines
Drugs
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Chronic Illness Segment is Expected to Hold the Major Market Share in the Pediatric Healthcare Market

  • The chronic illness segment is expected to account for the largest held the largest share of the pediatric healthcare market owing to their lower immunity leading to an increased demand for chronic disease treatment, Diarrhea and rise in injury-related cases are more common in children.
  • Based on the indication, asthma and allergies held the largest revenue due to various changes witnessed in childcare trends, increased pollution and decreased immunity, rise in the number of hospitals and clinics specific for childcare along with the rise in demand for the segment. On the other hand, metabolic disorders such as obesity, diabetes owing to the sedentary lifestyle due to lack of proper food and physical activity, rise in starvation among the pediatric population are fueling the growth of the segment.
Number of New Births per 1000, 2017

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the pediatric healthcare market owing to the rise in the volume of pediatric patient cases with kids suffering from autism, respiratory disorders, cerebral palsy, and muscular atrophy along with a steep rise in the adoption of advanced technologies in the U.S. which holds the major revenue share of market in North America. For instance, according to the American Academy of Allergy, Asthma & Immunology statistics - 2018, more than 40% of children have allergies in the U.S. resulting in high demand for pediatric healthcare fueling the market in the region. Furthermore, the launch of new products by key players for pediatric patients, rise in government initiatives to create awareness in people for pediatric treatments and disorders, improvements in healthcare infrastructure are likely to create a new opportunity for the global pediatric healthcare market over the forecast period.

geo -pD

Competitive Landscape

The Pediatric Healthcare Market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market.  Some prominent players are launching new products, while others are distributing the products. For instance, In April 2019, GSK today received approval from the U.S. Food and Drug Administration (FDA) for its intravenous (IV) Benlysta (belimumab), the first medicine in the US approved for children with systemic lupus erythematosus (SLE) from as young as five years of age cranial defects and consolidate their market positions across the globe. Some of the companies which are currently dominating the market are GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc, The Procter & Gamble Company, and C. H. Boehringer Sohn AG & Co KG.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Pediatric Diseases, such as Diabetes, Asthma and Rise in Affordability

      2. 4.2.2 Increased R&D Activities and Awareness of Pediatric Medicine Among Public

    3. 4.3 Market Restraints

      1. 4.3.1 Small Size of Study Population and Ethical Issues in Pediatric Research

      2. 4.3.2 Complications Associated with the Medicines that may Lead to Death

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type

      1. 5.1.1 Chronic Illness

      2. 5.1.2 Acute Illness

    2. 5.2 Treatment

      1. 5.2.1 Vaccines

      2. 5.2.2 Drugs

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 AxcanPharma USA

      3. 6.1.3 Boehringer Ingelheim International GmbH

      4. 6.1.4 Eli Lilly and Company

      5. 6.1.5 Fazzini Srl

      6. 6.1.6 GlaxosmithklinePlc

      7. 6.1.7 Gilead Sciences

      8. 6.1.8 Johnson & Johnson

      9. 6.1.9 Pfizer Inc

      10. 6.1.10 Sanofi S A

      11. 6.1.11 The Procter & Gamble Company

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Pediatric Healthcare Market market is studied from 2018 - 2026.

The Pediatric Healthcare Market is growing at a CAGR of >4.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

C. H. Boehringer Sohn AG & Co KG, GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc, The Procter & Gamble Company are the major companies operating in Pediatric Healthcare Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!